Literature DB >> 24392410

Neuroendocrine carcinoma of breast: a rare case vignette.

Nandeesh M1, Anitha T K2, Shravan Rajpurohit3, Santosh R3.   

Abstract

Neuroendocrine tumour of breast is an extremely rare condition. It may present as focal neuroendocrine differentiation with other histological subtypes of breast cancer or primary neuroendocrine tumour of breast or a metastatic foci in breast. There are no radiologic or clinical signs specific to this subtype. With rarity of its occurrence and absence of randomised trials regarding neuroendocrine tumour of breast, very little is known about the behaviour, prognosis and proper management of this condition. Only the available case reports suggests the necessary strategies for optimal management of this minimally explored medical condition.

Entities:  

Keywords:  Chemotherapy; Chromogranin; Immunohistochemistry; Neuroendocrine Carcinoma Breast

Year:  2013        PMID: 24392410      PMCID: PMC3879845          DOI: 10.7860/JCDR/2013/7051.3621

Source DB:  PubMed          Journal:  J Clin Diagn Res        ISSN: 0973-709X


  10 in total

1.  [ON THE CARCINOID GROWTH FORM OF THE CARCINOMA MAMMAE, ESPECIALLY THE CARCINOMA SOLIDUM (GELATINOSUM) MAMMAE].

Authors:  F FEYRTER; G HARTMANN
Journal:  Frankf Z Pathol       Date:  1963-10-03

2.  Endocrine ductal carcinoma in situ (E-DCIS) of the breast: a form of low-grade DCIS with distinctive clinicopathologic and biologic characteristics.

Authors:  W Y Tsang; J K Chan
Journal:  Am J Surg Pathol       Date:  1996-08       Impact factor: 6.394

3.  Primary mammary small-cell carcinoma: a molecular analysis of 2 cases.

Authors:  M P Hoang; A Maitra; A F Gazdar; J Albores-Saavedra
Journal:  Hum Pathol       Date:  2001-07       Impact factor: 3.466

4.  Neuroendocrine differentiation in carcinomas of the breast: a study of 51 cases.

Authors:  M Papotti; L Macrì; G Finzi; C Capella; V Eusebi; G Bussolati
Journal:  Semin Diagn Pathol       Date:  1989-05       Impact factor: 3.464

Review 5.  Primary neuroendocrine breast cancer, how much do we know so far?

Authors:  Homam Alkaied; Kassem Harris; Basem Azab; Qun Dai
Journal:  Med Oncol       Date:  2012-04-01       Impact factor: 3.064

6.  Neuroendocrine differentiation in breast cancer: established facts and unresolved problems.

Authors:  Luisella Righi; Anna Sapino; Caterina Marchiò; Mauro Papotti; Gianni Bussolati
Journal:  Semin Diagn Pathol       Date:  2010-02       Impact factor: 3.464

Review 7.  Primary small-cell neuroendocrine carcinoma of the breast: report of a case.

Authors:  Satoki Kinoshita; Akio Hirano; Kazumasa Komine; Susumu Kobayashi; Shigeya Kyoda; Hiroshi Takeyama; Ken Uchida; Toshiaki Morikawa; Jison Nagase; Goi Sakamoto
Journal:  Surg Today       Date:  2008-07-31       Impact factor: 2.549

8.  Synchronous metastases to the liver and pancreas from a primary neuroendocrine carcinoma of the breast diagnosed by fine-needle aspiration.

Authors:  Maria McIntire; Kalliopi Siziopikou; Jyothi Patil; Paolo Gattuso
Journal:  Diagn Cytopathol       Date:  2008-01       Impact factor: 1.582

9.  A 5-decade analysis of 13,715 carcinoid tumors.

Authors:  Irvin M Modlin; Kevin D Lye; Mark Kidd
Journal:  Cancer       Date:  2003-02-15       Impact factor: 6.860

Review 10.  Diffuse neuroendocrine differentiation in a morphologically composite mammary infiltrating ductal carcinoma: a case report and review of the literature.

Authors:  Odile David; Meena Bhattacharjee
Journal:  Arch Pathol Lab Med       Date:  2003-03       Impact factor: 5.534

  10 in total
  2 in total

1.  Bilateral Neuroendocrine Carcinoma of Breast: A Case Report.

Authors:  Sulochana Neupane; Sanam Dhakal; Shripad Walawalakar; Surya Bahadur Parajuli; Sulav Sapkota
Journal:  JNMA J Nepal Med Assoc       Date:  2021-12-11       Impact factor: 0.556

2.  The rare entity of bilateral and unilateral neuroendocrine metastases to the breast: a case series and literature review.

Authors:  Paola Zagami; Eleni Kandaraki; Giuseppe Renne; Franco Grimaldi; Francesca Spada; Alice Laffi; Nicola Fazio
Journal:  Ecancermedicalscience       Date:  2020-10-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.